Coherus Biosciences | CHRS - Ebitda





Ebitda Perubahan Tanggal
AbbVie USD 5.37B 1.85B 2025-12
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 80.26M 20.05M 2026-03
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
Baxter International USD -447M 873M 2025-12
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 12.14B 4.26B 2025-12
Fujifilm JPY 149.91B 17.19B 2026-03
Gilead Sciences USD 3.02B 1.01B 2025-12
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Merck USD 6.3B 2.09B 2025-12
Myriad Genetics USD 14.3M 4M 2025-12
Pacira USD 40.24M 1.53M 2026-03
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03
Xencor USD -51.05M 55.28M 2025-12
Zoetis USD 939M 101M 2025-12